DALLAS, June 1, 2016 /PRNewswire/ — Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions engineered to deliver optimal bone graft volume and graft-to-endplate contact, today announced the launch of its InFill® Anterior Lumbar Interbody Fusion (ALIF) Interbody Device. This device is designed to maximize wall thickness and graft chamber volume, ensuring optimal contact with the vertebral endplates by both the interbody device and bone graft material.
The InFill ALIF device is compatible with Pinnacle’s InFill® Graft Delivery System, which allows surgeons to deliver the optimal volume of graft material to the implant in situ without disrupting the interbody device’s placement, providing an opportunity to achieve maximum bone graft-to-endplate contact.
“Anterior lumbar spinal fusion is a common spine fusion technique, but often must be combined with an additional posterior approach to provide immediate stabilization. Science shows that in many unilateral posterior lumbar interbody fusion procedures, less than 50 percent of the disc area is actually grafted,” said Zach Sowell, President of Pinnacle Spine Group. “Pinnacle is committed to innovation that offers surgeons and patients options which address significant challenges in spinal fusion and enable more effective spinal fusion surgeries. We are excited to add the InFill ALIF device to our growing line of patented fusion systems.”
Features of the ALIF device include:
- Optimization for use in the L5/S1 disc space
- A gently bulleted nose for ease of insertion
- The option for in situ delivery of bone graft material to ensure a more complete fill
- A large graft chamber which facilitates formation of a robust fusion column
- An aggressive tooth design to prevent displacement of the device
- A large surface area which provides maximum contact with the apophyseal ring, helping to restore and maintain disc space and height
- Tantalum rod markers which provide excellent radiographic visualization of interbody device orientation and placement
Pinnacle Spine Group has pioneered the novel concept of placing bone graft material in situ into an implanted device in order to allow optimal bone graft material volume and maximized contact with vertebral endplates – a critical element for a successful spine fusion outcome.
Pinnacle Spine’s InFill Fusion Systems include a full line of innovative interbody fusion devices engineered for easier insertion, reduced subsidence through maximum contact with the apophyseal ring, a generous bone grafting chamber and compatibility with the InFill Graft Delivery System. The backbone of the technology is based on controlled and precise in situ placement of bone graft material.
Pinnacle recently announced its first international patent, a Chinese patent, which followed receipt of three U.S. patents on the InFill Fusion System. For more information on Pinnacle Spine Group’s unparalleled innovation, please visitPinnacleSpineGroup.com.
About Pinnacle Spine Group, LLC
Pinnacle Spine Group was founded with the focused goal of developing innovative medical devices, conceived in the operating room, for surgical procedures of the spine. The objective for every device and instrument we develop is a better outcome for the patient, and a better experience for the surgeon and operating room staff. Backed by the pioneering private equity firm Sowell & Co., Pinnacle is dedicated to developing advanced technologies that offer greater opportunities for positive patient outcomes. The team applies innovative thinking to deliver implants and instrumentation that simplify and enhance the surgical procedure.
SOURCE Pinnacle Spine Group, LLC